HHS proposes changes to loosen warnings on testosterone therapy

HHS is requesting changes to prescribing information for testosterone therapy products following a review of new clinical data and scientific evidence, according to a press release from the agency. As Healio previously reported, the FDA convened a panel in December that discussed removing some contraindications for testosterone therapy as well as taking testosterone therapy off the list of